FDA Inspection
Bi-Coastal Pharma InternationalFDA Inspection 1161078 - Bi-Coastal Pharma International - January 14, 2022
Discuss this record with AI
Record Details
This FDA Inspection record concerns Bi-Coastal Pharma International, with an inspection on January 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 22b8b76f-f16b-4d9d-af96-e43b2e232e7a
Violation Codes5
21 CFR 211.166(a)21 CFR 211.198(a)21 CFR 211.198(b)(2)21 CFR 211.22(d)21 CFR 211.25(b)
Full citation text and observation details available on the Dashboard.